Comparing Quviviq vs Suvorexant
Quviviq (daridorexant) | Suvorexant |
|
---|
Quviviq (daridorexant) | Suvorexant |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Insomnia. Quviviq may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Insomnia. Suvorexant may also be used for purposes not listed in this medication guide. |
Related suggestions Insomnia
|
|||||||
More about Quviviq (daridorexant) | More about Suvorexant | ||||||||
Ratings & Reviews | |||||||||
Quviviq has an average rating of 5.1 out of 10 from a total of 155 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 46% reported a negative effect. |
Suvorexant has an average rating of 3.9 out of 10 from a total of 567 ratings on Drugs.com. 27% of reviewers reported a positive effect, while 61% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Quviviq side effects |
View all Suvorexant side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Quviviq prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
N/A |
Belsomra | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
8 hours |
12 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
||||||||
Pregnancy Category | |||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 681 drugs are known to interact with Quviviq:
|
A total of 495 drugs are known to interact with Suvorexant:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
January 07, 2022 |
August 13, 2014 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Ativan
Ativan is a benzodiazepine used to treat anxiety disorders or anxiety associated with depression ...
Benadryl
Benadryl is an antihistamine and is used to treat sneezing, runny nose, itching and other ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Ambien
Ambien (zolpidem) is a prescription sedative used to treat insomnia, helping you fall asleep and ...
Lunesta
Lunesta is a sedative and is used to treat insomnia. Lunesta's effects typically begin within 30 ...
Belsomra
Belsomra (suvorexant) is used to treat insomnia. Includes Belsomra side effects, interactions and ...
Restoril
Restoril (temazepam) is a benzodiazepine used to treat insomnia symptoms. Includes Restoril side ...
Dayvigo
Dayvigo (lemborexant) is a sleeping tablet used to help adults with insomnia fall asleep faster and ...
Banophen
Banophen is used for allergic reactions, allergic rhinitis, cold symptoms, cough, extrapyramidal ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.